Regulatory updates, especially from the FDA, are critical for pharmaceutical companies as they directly impact the company's ability to market and sell their products. A positive update can lead to increased investor confidence and a potential rise in stock price due to anticipated growth in sales and market expansion. While the exact nature of the update isn't detailed, the announcement itself suggests progress, which is generally viewed positively by the market.